Conventions Psychiatry & Counseling proudly announces its partnership with Apollo and NeuroStar TMS to offer Transcranial Magnetic Stimulation (TMS) therapy, an innovative treatment for depression. This non-invasive therapy utilizes a magnet, akin to those used in MRI machines, to stimulate nerve cells in the brain that control mood.
TMS therapy has demonstrated promising results in providing long-term remission of depression symptoms by positively impacting neurotransmitter levels. Patients experience a tapping sensation and a clicking sound while reclining in a comfortable chair throughout each treatment session. These sessions, lasting between 19 and 37 minutes, are administered five days a week for four to six weeks.
One of the key benefits of TMS treatment is its non-invasive nature, ensuring a safe and easy experience for patients. Additionally, TMS therapy is approved by most insurances, increasing accessibility for those seeking help. Patients can drive themselves to and from the sessions as there are no effects on alertness or memory.
Conventions Psychiatry & Counseling, in collaboration with Apollo and NeuroStar TMS, is excited to provide this groundbreaking therapy to individuals battling depression. With the potential to revolutionize future depression care, TMS treatment aims to enhance mental health and overall quality of life.
For more information or to schedule a consultation, please contact Conventions Psychiatry & Counseling at (630) 642 – 1801 or visit https://conventionstms.com.
This press release is distributed by the Newsworthy.ai™ Press Release Newswire – News Marketing Platform™. Reference URL for this press release is here.
